S
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79381826
- Registration number
- 7574830
- Mark type
- Word mark
- Filed
- 26 Jul 2023
- Published for opposition
- 24 Sept 2024
- Registered
- 26 Nov 2024
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Chemicals used in industry and science, in particular active substances, auxiliaries and intermediate products for chemicals and types of chemicals; chemicals used in industry, namely, for the cosmetics industry; excipients being inert bases for the manufacture of pharmaceutical preparations; excipients for use in the manufacture of medical and veterinary preparations
- Class 002 — Paints: Colors, dyes, colorants, namely, colorants and additives in the nature of coloring and dyes for the manufacture of foodstuffs and food supplements
- Class 003 — Cosmetics and cleaning preparations: Cosmetic non-medicated products, namely, cosmetic preparations, make-up; body care and beauty products, namely, body and beauty care cosmetics
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, cardiovascular pharmaceutical preparations, antimycotic agents, antifungal agents, anticoagulant agents, anticancer drugs, analgesics, anorexiants, anticonvulsants, antiemetics, anti-Parkinson's, anticarcinoma, anxiolytics, sedatives and hypnotics, cholinergic agonists, cholinesterase inhibitors, CNS stimulants, general anesthetics, muscle relaxants, oral hypoglycemic agents, oral antihyperglycemic agents, biguanides, sulfonylureas, meglitinides, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, thiazolidinediones (TZDs), and alpha-glucosidase inhibitors; active substances (APIs), drug substance intermediates (DSIs) and excipients for medicines and pharmaceutical products, namely, active pharmaceutical ingredients and drug substance intermediates all being pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; medical and veterinary preparations for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; active substances and intermediate products for medical and veterinary preparations , namely, pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; dietetic foods and beverages for medical or veterinary purposes; food ingredients and additives being dietetic foods and beverages adapted for medical use; food for babies; ingredients and additives being food for babies food supplements for humans and animals; ingredients and additives being food supplements
- Class 039 — Transportation and storage services: Transport services, namely, transportation of goods; packaging and storage of merchandise, in particular packaging, storage and transport of raw materials for the pharmaceutical and food industry as well as finished generic pharmaceutical products
- Class 042 — Scientific and technological services: Scientific and technological services, namely, development of generic medicine products; industrial analysis, quality control and authentication services, particularly for the pharmaceutical and nutritional industry in the fields of quality assurance and analysis, regulatory authorization and regulatory affairs
Owner
- Selectchemie AG, CH
- Selectchemie AG, CH
- Selectchemie AG, CH
Prosecution history
- 17 May 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Apr 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Apr 2025 — FINAL DISPOSITION PROCESSED
- 12 Apr 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 25 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 26 Feb 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE